Interviews/Contributions Investor Insights: Sabir Rassiwalla – What Makes CRG Different From Other Healthcare Investors? (Part 2) Share by Ken Dropiewski on September 14, 2022 More in Interviews/Contributions: Investor Insights: Jan and Jeff from Arboretum Share Their Outlook on MedTech Investing October 2, 2026 Investor Insights: Arboretum – Stage of investment September 24, 2026 Investor Insights – Jeff Terrell and Jan Garfinkle of Aboretum: What Do They Look for and How to Best Prepare for Them September 14, 2026 Share this story Facebook Twitter LinkedIn McDermott + Bull Partner Ken Dropiewski talks with CRG Director Sabir Rassiwalla about how CRG is different from healthcare investment partners in the market.